Clinical Trial Update: Gemcitabine and Monoclonal Antibody Therapy in Treating Patients With Metastatic Cancer of the Pancreas [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating gemcitabine in combination with a monoclonal antibody therapy for metastatic pancreatic cancer; the current status of the study is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Monoclonal antibody therapy

Snippet

Sponsor: Brown University | Conditions: Pancreatic Cancer | Phase 2 | Status: UNKNOWN